Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 15;10(5):621.
doi: 10.3390/nu10050621.

Iron Status and Gestational Diabetes-A Meta-Analysis

Affiliations
Review

Iron Status and Gestational Diabetes-A Meta-Analysis

Yachana Kataria et al. Nutrients. .

Abstract

A meta-analysis of the association of iron overload with gestational diabetes mellitus (GDM) may inform the health debate. We performed a meta-analysis investigating the association of iron biomarkers and dietary iron exposure with GDM. We identified 33 eligible studies (N = 44,110) published in 2001⁻2017. The standardized mean differences (SMD) in women who had GDM compared to pregnant women without were 0.25 µg/dL (95% CI: 0.001⁻0.50) for iron, 1.54 ng/mL (0.56⁻2.53) for ferritin, 1.05% (0.02 to 2.08) for transferrin saturation, and 0.81 g/dL (0.40⁻1.22) for hemoglobin. Adjusted odds ratio for GDM were 1.58 (95% CI: 1.20⁻2.08) for ferritin, 1.30 (1.01⁻1.67) for hemoglobin, and 1.48 (1.29⁻1.69) for dietary heme intake. We did not find any differences in TIBC or transferrin concentration in women with and without GDM. We also did not find any association of increased transferrin receptor or increased intake of total dietary iron, non-heme iron or supplemental iron, with increased odds ratios for GDM. Considerable heterogeneity was present among the studies (0⁻99%), but no evidence of publication bias. Accumulating evidence suggests that circulating and dietary iron biomarkers among pregnant women are associated with GDM, but the results should be interpreted with caution due to the high heterogeneity of analyses. Randomized trials investigating the benefits of iron reduction in women at high risk for GDM are warranted.

Keywords: ferritin; gestational diabetes; iron; pregnancy; transferrin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Selection of studies. Note: Australia, Europe, and USA were clustered due to the limited number of studies in individual analyses.
Figure 2
Figure 2
Blood and dietary iron biomarkers and gestational diabetes status (mean difference).
Figure 3
Figure 3
Ferritin concentration (ng/mL) differences in GDM—standardized mean differences.
Figure 4
Figure 4
Adjusted association between ferritin concentration (ng/mL) and GDM—adjusted odds ratio.
Figure 5
Figure 5
Differences in iron and gestational diabetes status (odds ratio).
Figure 6
Figure 6
Hemoglobin concentration (g/dL) differences in GDM—standardized mean difference.

References

    1. Benoist B.D., McLean E., Egll I., Cogswell M. Worldwide Prevalence of Anaemia 1993–2005: WHO Global Database on Anaemia. WHO; Geneva, Switzerland: 2008. Worldwide prevalence of anaemia 1993–2005: Who global database on anaemia.
    1. Hansen J.B., Moen I.W., Mandrup-Poulsen T. Iron: The hard player in diabetes pathophysiology. Acta Physiol. 2014;210:717–732. doi: 10.1111/apha.12256. - DOI - PubMed
    1. O’Sullivan J.B., Mahan C.M. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278. - PubMed
    1. World Health Organization . Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. WHO; Geneva, Switzerland: 2013. - PubMed
    1. Chiefari E., Arcidiacono B., Foti D., Brunetti A. Gestational diabetes mellitus: An updated overview. J. Endocrinol. Investig. 2017;40:899–909. doi: 10.1007/s40618-016-0607-5. - DOI - PubMed

LinkOut - more resources